675185-27-0

Basic information

• Product Name: (R)-1-Boc-2-acetyl-pyrrolidine
• Synonyms: (R)-1-Boc-2-acetyl-pyrrolidine;tert-butyl (R)-2-formylpyrrolidine-1-carboxylate;(R)-tert-Butyl 2-acetylpyrrolidine-1-carboxylate;tert-butyl (2R)-2-acetylpyrrolidine-1-carboxylate
• CAS NO: 675185-27-0
• Molecular Formula: C₁₁H₁₉NO₃
• Molecular Weight: 213.27346
• Mol File: 675185-27-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (R)-1-Boc-2-acetyl-pyrrolidine(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1-Boc-2-acetyl-pyrrolidine(675185-27-0)
• EPA Substance Registry System: (R)-1-Boc-2-acetyl-pyrrolidine(675185-27-0)

Safety Data

• Hazardous Substances Data: 675185-27-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
(R)-1-Boc-2-acetyl-pyrrolidine is utilized as a key building block for the construction of complex organic molecules. Its presence of a Boc protecting group and acetyl functionality allows for selective reactions and subsequent deprotection steps, enabling the synthesis of a wide range of chemical entities.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (R)-1-Boc-2-acetyl-pyrrolidine serves as an intermediate in the synthesis of various drug candidates. Its unique structure contributes to the development of new therapeutic agents, particularly those targeting complex biological pathways or requiring specific stereochemistry for optimal activity.
Used in Medicinal Chemistry:
(R)-1-Boc-2-acetyl-pyrrolidine is employed as a valuable tool in medicinal chemistry for the design and optimization of bioactive molecules. Its reactivity and structural features allow for the fine-tuning of molecular properties, such as potency, selectivity, and pharmacokinetics, which are crucial for the development of effective drugs.
Used in Drug Development:
In the drug development process, (R)-1-Boc-2-acetyl-pyrrolidine plays a role in the creation of novel pharmaceutical compounds. Its incorporation into the molecular framework can lead to the discovery of new drugs with improved therapeutic profiles, including enhanced efficacy, reduced side effects, and better patient compliance.

Upstream product

• 676-58-4 methylmagnesium chloride 
• 288086-98-6 [tert-butyl (R)-2-(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate] 
• 75-16-1 methylmagnesium bromide 
• 37784-17-1 N-(tert-butoxycarbonyl)-D-proline 

Relevant articles and documents

COMPOUNDS TARGETING RNA-BINDING PROTEINS OR RNA-MODIFYING PROTEINS

The invention relates to a compound represented by Formula (I): or a pharmaceutically acceptable salt thereof, compositions comprising the same and methods of preparing and using the same. The variables are described herein.

MUSCARINIC AGONISTS

This invention relates to compounds that are agonists of the muscarinic M4 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1a or a salt thereof, wherein n, p, Q, R1, R2, R3, R9 and R4 are as defined herein.

QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS

A quinazoline derivative of the formula (I): (A chemical formula should be inserted here - please see paper copy enclosed) Formula I wherein the substituents are as defined in the text for use in the production of an anti proliferative effect which effect is produced alone or in part by inhibiting erbB2 receptor tyrosine kinase in a warm blooded animal such as man.

SULPHONAMIDE DERIVATIVES AND THEIR USE AS TACE INHIBITORS

Sulphonamide derivatives that are useful in the inhibition of metalloproteinases and in particular in the inhibition of TNF-α Converting Enzyme (TACE).